- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,314.45
7D
-0.6%
1Y
25.5%
Divi's Laboratories
Market Cap: ₹1.6t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹6,087.00
7D
2.7%
1Y
52.1%